JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sidney Levitsky
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCully, J. D.
Right arrow Articles by Levitsky, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCully, J. D.
Right arrow Articles by Levitsky, S.

J Thorac Cardiovasc Surg 1998;116:154-158
© 1998 Mosby, Inc.


Cardiopulmonary Support And Physiology

Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart

James D. McCully, PhD, Masahisa Uematsu, MD, Robert A. Parker, ScD, Sidney Levitsky, MD

This study was supported by the National Institutes of Health (HL 29077) and the American Heart Association.

Received for publication April 17, 1997. Revisions requested June 6, 1997; revisions received Feb. 11, 1998. Accepted for publication Feb. 19, 1998. Address for reprints: James D. McCully, PhD, Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, 110 Francis St., Suite 2C, Boston, MA 02215.

Objective: The purpose of this study was to determine the effect of an intracoronary bolus injection of adenosine used in concert with ischemic preconditioning on postischemic functional recovery and infarct size reduction in the rabbit heart and to compare adenosine-enhanced ischemic preconditioning with ischemic preconditioning and magnesium-supplemented potassium cardioplegia.
Methods: New Zealand White rabbits (n = 36) were used for Langendorff perfusion. Control hearts were perfused at 37° C for 180 minutes; global ischemic hearts received 30 minutes of global ischemia and 120 minutes of reperfusion; magnesium-supplemented potassium cardioplegic hearts received cardioplegia 5 minutes before global ischemia; ischemic preconditioned hearts received 5 minutes of zero-flow global ischemia and 5 minutes of reperfusion before global ischemia; adenosine-enhanced ischemic preconditioned hearts received a bolus injection of adenosine just before the preconditioning. To separate the effects of adenosine from adenosine-enhanced ischemic preconditioning, a control group received a bolus injection of adenosine 10 minutes before global ischemia.
Results: Infarct volume in global ischemic hearts was 32.9% ± 5.1% and 1.03% ± 0.3% in control hearts. The infarct volume decreased (10.23% ± 2.6% and 7.0% ± 1.6%, respectively; p < 0.001 versus global ischemia) in the ischemic preconditioned group and control group, but this did not enhance postischemic functional recovery. Magnesium-supplemented potassium cardioplegia and adenosine-enhanced ischemic preconditioning significantly decreased infarct volume (2.9% ± 0.8% and 2.8% ± 0.55%, respectively; p < 0.001 versus global ischemia, p = 0.02 versus ischemic preconditioning and p = 0.05 versus control group) and significantly enhanced postischemic functional recovery.
Conclusions: Adenosine-enhanced ischemic preconditioning is superior to ischemic preconditioning and provides equal protection to that afforded by magnesium-supplemented potassium cardioplegia.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. D. Tune, M. W. Gorman, and E. O. Feigl
Matching coronary blood flow to myocardial oxygen consumption
J Appl Physiol, July 1, 2004; 97(1): 404 - 415.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Vinten-Johansen, Z.-Q. Zhao, J. S. Corvera, C. D. Morris, J. M. Budde, V. H. Thourani, and R. A. Guyton
Adenosine in myocardial protection in on-pump and off-pump cardiac surgery
Ann. Thorac. Surg., February 1, 2003; 75(2): S691 - 699.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Suematsu, T. Ohtsuka, H. Horimoto, K. Maeda, Y. Nakai, S. Mieno, and S. Takamoto
Long-term treatment with nipradilol, a nitric oxide-releasing {beta}-adrenergic blocker, enhances postischemic recovery and limits infarct size
Ann. Thorac. Surg., January 1, 2002; 73(1): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Mubagwa and W. Flameng
Adenosine, adenosine receptors and myocardial protection: An updated overview
Cardiovasc Res, October 1, 2001; 52(1): 25 - 39.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Toyoda, S. Khan, W. Chen, R. A. Parker, S. Levitsky, and J. D. McCully
Effects of NHE-1 inhibition on cardioprotection and impact on protection by K/Mg cardioplegia
Ann. Thorac. Surg., September 1, 2001; 72(3): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Stadler, J. Phillips, Y. Toyoda, M. Federman, S. Levitsky, and J. D. McCully
Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion
Ann. Thorac. Surg., August 1, 2001; 72(2): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Suematsu, T. Ohtsuka, Y. Hirata, K. Maeda, K. Imanaka, and S. Takamoto
L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts
Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Toyoda, S. Levitsky, and J. D. McCully
Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection
Ann. Thorac. Surg., April 1, 2001; 71(4): 1281 - 1288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. McCully, Y. Toyoda, M. Uematsu, R. D. Stewart, and S. Levitsky
Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H591 - H602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Toyoda, I. Friehs, R. A. Parker, S. Levitsky, and J. D. McCully
Differential role of sarcolemmal and mitochondrial KATP channels in adenosine-enhanced ischemic preconditioning
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2694 - H2703.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. E. Johnston
Preconditioning the Brain and Heart: Implications for Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. McCully, M. Uematsu, and S. Levitsky
Adenosine-enhanced ischemic preconditioning provides myocardial protection equal to that of cold blood cardioplegia
Ann. Thorac. Surg., March 1, 1999; 67(3): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. McCully, M. Uematsu, R. A. Parker, and S. Levitsky
Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart
Ann. Thorac. Surg., December 1, 1998; 66(6): 2037 - 2043.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The American Association for Thoracic Surgery.